Medtronic relief as CoreValve injunction postponed
This article was originally published in Clinica
Executive Summary
Medtronic has got a reprieve, at least for now, in its ongoing legal battle with transcatheter aortic valve implant (TAVI) rival Edwards Lifesciences. In the latest twist, the appeals court has postponed an injunction granted to Edwards earlier this month. The injunction was set to come into force on 23 April.